Bidasoa Integrated Health Organization
Hondarribia, Gipuzkoa, 20270, Spain
NCT Number: NCT03840018
It was a randomised intervention study, with before-and-after outcome measures and a control group, in patients who had an active long-term prescription for PPIs at high doses for at least 6 months.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Hondarribia, Gipuzkoa, 20270, Spain
The intervention consisted of sending patients an informative letter by post, in which their doctor invited them to seek an appointment for a medication review. Control group patients did not receive such a letter, and they were treated as usual (their doctors received a list of identifiers of patients on high doses).
The main outcome variable was the number of active prescriptions of each PPI dose (high dose/standard dose/treatment cessation) at 6 months after the intervention.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients received an informative letter by post, in which their doctor invited them to seek an appointment for a medication review
Time frame: 6 months
Number of active prescriptions of each proton pump inhibitors dose (high dose/standard dose/treatment cessation) at 6 months after the intervention
Osakidetza
Other
Randomized Trial to Assess the Effectiveness of a Postal Intervention for Reducing the Chronic Use of Highe Doses of Proton Pump Inhibitors
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05096429
Behavior, Chemically-Induced Disorders
Providence, Rhode Island, United States
View Trial DetailsNCT04372238
Chemically-Induced Disorders, Drug Misuse
Providence, Rhode Island, United States
View Trial DetailsNCT03838510
Chemically-Induced Disorders, Drug Misuse
San Francisco, California, United States
View Trial DetailsNCT02093559
Chemically-Induced Disorders, Drug Misuse
San Francisco, California, United States
View Trial Details